SCHEMBL27179628

SCHEMBL27179628

Cc1ccccc1NS(=O)(=O)c1cc(C(=O)Nc2cccc([N+](=O)[O-])c2)ccc1Cl

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 11/20 0.84
▸ MEN1 O00255 10/20 0.84
▸ KMT2A Q03164 10/20 0.84
▸ LMNA P02545 6/20 0.84
▸ ALDH1A1 P00352 6/20 0.84
▸ SMN1; SMN2 Q16637 3/20 0.84
▸ HTT P42858 2/20 0.84
▸ MAPK1 P28482 1/20 0.84
▸ SLC25A1 P53007 1/20 0.63
▸ KDM4E B2RXH2 3/20 0.61
▸ NPSR1 Q6W5P4 3/20 0.61
▸ POLB P06746 3/20 0.61
▸ CYP1A2 P05177 1/20 0.55
▸ CYP3A4 P08684 1/20 0.55
▸ CYP2D6 P10635 1/20 0.55
▸ CYP2C9 P11712 1/20 0.55
▸ CYP2C19 P33261 1/20 0.55
▸ DDX3X O00571 1/20 0.55
▸ TDP1 Q9NUW8 1/20 0.55
▸ IDH1 O75874 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27179434 0.91 MAPT (1.00) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL27181018 0.84 MEN1 (0.77) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL30926768 0.84 MEN1 (0.77) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL27181450 0.84 KMT2A (0.62) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL27179646 0.84 MEN1 (0.69) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL27180386 0.82 MAPT (0.92) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL27181573 0.81 MAPT (0.81) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL30926943 0.81 MAPT (0.81) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL30926792 0.81 MAPT (0.85) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL27180794 0.81 MAPT (0.85) MAPTMEN1KMT2ALMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4580404-A2 SULFONAMIDE APYRASE INHIBITORS Texas Crop Science, Inc. (US) 2025-07-09 — — EP claimed
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS TEXAS CROP SCIENCE, INC. 2024-03-28 — — US claimed
WO-2024050041-A2 SULFONAMIDE APYRASE INHIBITORS TEXAS CROP SCIENCE (US) 2024-03-07 — — WO claimed
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS TEXAS CROP SCIENCE, INC. 2024-03-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS APEH, ARSA, DNPEP MAPT 4236/4885MEN1 4795/4885KMT2A 2544/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback